|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 14/725 | (2006.01) | ||
| C07K 7/06 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3795177 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20193185.4 |
| Date of filing the European patent application | 2016-05-09 | |
| (97) | Date of publication of the European application | 2021-03-24 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-13 |
| (46) | Date of publication of the claims translation | 2022-08-10 |
| (30) | Number | Date | Country code |
| PCT/EP2015/060357 | 2015-05-11 | WO |
| (72) |
SAHIN, Ugur , DE
TÜRECI, Özlem , DE
SIMON, Petra , DE
OMOKOKO, Tana , DE
BREITKREUZ, Andrea , DE
MROZ, Karolina Anna , DE
HEBICH, Lisa , DE
|
| (73) |
BioNTech Cell & Gene Therapies GmbH ,
An der Goldgrube 12, 55131 Mainz,
DE
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Klaudinui 18.2 specifiniai imunoreceptoriai ir T ląstelių epitopai |
| CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 10 | 231.00 EUR |
| 2026-05-09 |